Biochemical / Biophysical Kinetics Made Easy

Similar documents
Biochemical Kinetics Made Easier

I N N O V A T I O N L E C T U R E S (I N N O l E C)

Irreversible Inhibition Kinetics

Algebraic solution for time course of enzyme assays. Enzyme kinetics in the real world. Progress curvature at low initial [substrate]

A New 'Microscopic' Look at Steady-state Enzyme Kinetics

Implementation of the King-Altman method in DynaFit

I N N O V A T I O N L E C T U R E S (I N N O l E C) Binding and Kinetics for Experimental Biologists Lecture 3 Equilibrium binding: Theory

etc. Lecture outline Traditional approach is based on algebraic models Algebraic models restrict experiment design

Integrated Michaelis-Menten equation in DynaFit. 3. Application to HIV protease

LanthaScreen Eu Kinase Binding Assay Validation Packet. Optimization of a LanthaScreen Eu Kinase Binding Assay for AURKB

Petr Kuzmič, Ph.D. BioKin, Ltd.

LanthaScreen Eu Kinase Binding Assay Validation Packet. Optimization of a LanthaScreen Eu Kinase Binding Assay for RPS6KA1

Numerical Enzymology

I N N O V A T I O N L E C T U R E S (I N N O l E C) Petr Kuzmič, Ph.D. BioKin, Ltd. WATERTOWN, MASSACHUSETTS, U.S.A.

LanthaScreen Eu Kinase Binding Assay Validation Packet

Characterization of Reversible Kinase Inhibitors using Microfluidic Mobility-Shift Assays

LanthaScreen Eu Kinase Binding Assay Validation Packet. Optimization of a LanthaScreen Eu Kinase Binding Assay for STK33

Optimization of a LanthaScreen Eu Kinase Binding Assay for PIK3CA/PIK3R1

CHAPTER 8 Analysis of FP Binding Data

LanthaScreen Eu Kinase Binding Assay for GAK

A. One-Substrate Reactions (1) Kinetic concepts

After lectures by. disappearance of reactants or appearance of. measure a reaction rate we monitor the. Reaction Rates (reaction velocities): To

SIMPLE MODEL Direct Binding Analysis

Supplemental Materials and Methods

ENZYME KINETICS. Medical Biochemistry, Lecture 24

Chapter 14. Enzyme Kinetics

Optimization of an Adapta Kinase Assay for CAMK1

ENZYME KINETICS AND INHIBITION

Mathematical model of serodiagnostic immunochromatographic assay

Online Supplementary Material. Messenger RNA Interactions in the Decoding Center Control the Rate of Translocation

Supporting Information Converter domain mutations in myosin alter structural kinetics and motor function. Hershey, PA, MN 55455, USA

Name Student number. UNIVERSITY OF GUELPH CHEM 4540 ENZYMOLOGY Winter 2002 Quiz #1: February 14, 2002, 11:30 13:00 Instructor: Prof R.

Macromolecular Interactions the equilibrium element

Isothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017

TOPIC 6: Chemical kinetics

Problem Set 5 Question 1

Concept review: Binding equilibria

Basic Principles of Kinetics and Thermodynamics Arthur L. Haas, Ph.D. Department of Biochemistry and Molecular Biology

Characterizing degradation kinetics and cellular mechanisms of PROTAC compounds. Kristin M. Riching, Ph.D. Protein Degradation Therapeutics 2018

Kinetics. Consider an irreversible unimolecular reaction k. -d[a]/dt = k[a] Can also describe in terms of appearance of B.

Rate laws, Reaction Orders. Reaction Order Molecularity. Determining Reaction Order

Chemical Kinetics. Topic 7

Determination of substrate kinetic parameters from progress curve data

Society for Biomolecular Screening 10th Annual Conference, Orlando, FL, September 11-15, 2004

Kinetic Models of Protein Binding

Enzyme Nomenclature Provides a Systematic Way of Naming Metabolic Reactions

Supporting information

BMB Lecture 9

Lecture 15 (10/20/17) Lecture 15 (10/20/17)

Part II => PROTEINS and ENZYMES. 2.7 Enzyme Kinetics 2.7a Chemical Kinetics 2.7b Enzyme Inhibition

CHM 5423 Atmospheric Chemistry Notes on kinetics (Chapter 4)

it is assumed that only EH and ESH are catalytically active Michaelis-Menten equation for this model is:

Binding Theory Equations for Affinity and Kinetics Analysis

Chemical Kinetics. What quantities do we study regarding chemical reactions? 15 Chemical Kinetics

Chapter 11: CHEMICAL KINETICS

Problem Set 2. 1 Competitive and uncompetitive inhibition (12 points) Systems Biology (7.32/7.81J/8.591J)

Free energy simulations

Program for the rest of the course

Take advantage of time in your experiments: a guide to simple, informative kinetics assays

Chemical Kinetics. Chapter 13. Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.

Comprehensive Enzyme Kinetics

Pig Muscle Lactate Dehydrogenase with Oxidized Nicotinamide-Adenine

Chapter 14 Chemical Kinetics

ChemE Chemical Kinetics & Reactor Design Solutions to Exercises for Calculation Session 3

Chapter 6: Outline-2. Chapter 6: Outline Properties of Enzymes. Introduction. Activation Energy, E act. Activation Energy-2

Added topics: depend on time/rate - Skipped

Regulation of metabolism

Chapter 14: Chemical Kinetics

LineShapeKin NMR Line Shape Analysis Software for Studies of Protein-Ligand Interaction Kinetics

Enzymes Part III: Enzyme kinetics. Dr. Mamoun Ahram Summer semester,

13 Determining the Efficiency of the Enzyme Acetylcholine Esterase Using Steady-State Kinetic Experiment

Chapter 12, Chemical Kinetics

2013 W. H. Freeman and Company. 6 Enzymes

Prof. Jason D. Kahn Your Signature: Exams written in pencil or erasable ink will not be re-graded under any circumstances.

Theoretical Models for Chemical Kinetics

Diffusion influence on Michaelis Menten kinetics

PETER PAZMANY CATHOLIC UNIVERSITY Consortium members SEMMELWEIS UNIVERSITY, DIALOG CAMPUS PUBLISHER

Chapter 14 Chemical Kinetics

CHM333 LECTURES 14 & 15: 2/15 17/12 SPRING 2012 Professor Christine Hrycyna

From cell biology to Petri nets. Rainer Breitling, Groningen, NL David Gilbert, London, UK Monika Heiner, Cottbus, DE

The reaction whose rate constant we are to find is the forward reaction in the following equilibrium. NH + 4 (aq) + OH (aq) K b.

BCH 3023 Fall 2008 Exam 2, Form C Name: ANSWER KEY

Lecture 27. Transition States and Enzyme Catalysis

K ex. Conformational equilibrium. equilibrium K B

Physical Pharmacy. Chemical Kinetics and Stability

Lecture 11: Enzymes: Kinetics [PDF] Reading: Berg, Tymoczko & Stryer, Chapter 8, pp

Chapter 8. Enzymes: basic concept and kinetics

Lecture 11: Enzyme Kinetics, Part I

ENZYME SCIENCE AND ENGINEERING PROF. SUBHASH CHAND DEPARTMENT OF BIOCHEMICAL ENGINEERING AND BIOTECHNOLOGY IIT DELHI LECTURE 7

Problem Set # 3

CHEM 341 PHYSICAL CHEMISTRY FINAL EXAM. Name

Examples of fast and slow reactions

Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition

BIOCHEMISTRY - CLUTCH REVIEW 2.

The Diffusion Coefficient for PGK Folding in Eukaryotic Cells

11/9/2012 CHEMICAL REACTIONS. 1. Will the reaction occur? 2. How far will the reaction proceed? 3. How fast will the reaction occur?

On the status of the Michaelis-Menten equation and its implications for enzymology

Improved Rate Constant Estimates Using the BIAcore

Determination of Binding Affinities and Molecular Mechanisms case studies with nucleotide binding proteins

1. Introduction to Chemical Kinetics

Transcription:

Biochemical / Biophysical Kinetics Made Easy Software DYNAFIT in drug discovery research Petr Kuzmič, Ph.D. BioKin, Ltd. 1. Theory: differential equation models - DYNAFIT software 2. Example: lanthascreen Eu assay in kinetic mode - p38a kinase / antibody / tracer - p38a kinase / antibody / tracer / desatinib The task of mechanistic kinetics SELECT AMONG MULTIPLE CANDIDATE MECHANISMS E + S E.S E + P fluorescence E + I E.I competitive? uncompetitive? mixed type? MECHANISMS computer DATA time Select most plausible model Bio/Chemical Kinetics Made Easy 2 1

From mechanistic to mathematical models DERIVE A MATHEMATICAL MODEL FROM BIOCHEMICAL/BIOPHYSICAL IDEAS k +1 k +2 E + S E.S E + P k -1 fluorescence E + I k +3 k -3 E.I MECHANISM time v = k+ 2[ E] k 3 ( k 1 + k + 2 k+ 1k 3[ S] ) + k k [ S] + k 3 + 1 + 3 ( k 1 + k + 2 )[ I] DATA MATHEMATICAL MODEL computer Bio/Chemical Kinetics Made Easy 3 Problem: Simple mechanisms... MERELY FIVE REACTIONS... E + A E + B E.A + B E.A.B + A E.B E + P 2 reactants (A, B) 1 product (P) 5 10 reversible reactions rate constant "RANDOM BI-UNI" MECHANISM Bio/Chemical Kinetics Made Easy 4 2

... lead to complex algebraic models MERELY FIVE REACTIONS... Segel, I. (1975) Enzyme Kinetics. John Wiley, New York, p. 646. E + A E + B E.A + B E.A.B + A E.B E + P "RANDOM BI-UNI" MECHANISM Bio/Chemical Kinetics Made Easy 5 New approach: Numerical Kinetics NO MORE ALGEBRA: LET THE COMPUTER DEAL WITH IT! Bio/Chemical Kinetics Made Easy 6 3

Theoretical foundations: Mass Action Law RATE IS PROPORTIONAL TO CONCENTRATION(S) MONOMOLECULAR REACTIONS A products rate is proportional to [A] -d [A] / d t = k [A] BIMOLECULAR REACTIONS A + B products rate is proportional to [A] [B] -d [A] / d t = - d [B] / d t = k [A] [B] Bio/Chemical Kinetics Made Easy 7 Theoretical foundations: Mass Conservation Law PRODUCTS ARE FORMED WITH THE SAME RATE AS REACTANTS DISAPPEAR EXAMPLE A P + Q - d[ A ]/dt = + d[ P ]/dt = + d[ Q]/dt COMPOSITION RULE ADDITIVITY OF TERMS FROM SEPARATE REACTIONS mechanism: A k 1 B d [B] / d t = + k 1 [A] - k 2 [B] B k 2 C Bio/Chemical Kinetics Made Easy 8 4

Software package DYNAFIT REFERENCES 1. Kuzmic P. (1996) Anal. Biochem. 237, 260-273. Program DYNAFIT for the analysis of enzyme kinetic data 2. Kuzmic P. (2009) Meth. Enzymol., 467, 247-280. DYNAFIT A software package for enzymology DYNAFIT paper - cumulative citations 800 700 600 500 400 300 200 100 0 1998 2000 2002 2004 2006 2008 2010 2012 Bio/Chemical Kinetics Made Easy 9 A "Kinetic Compiler" HOW DYNAFIT PROCESSES YOUR BIOCHEMICAL EQUATIONS k 1 E + S E.S E + P k 2 k 3 Input (plain text file): Rate terms: Rate equations: E + S ---> ES : k1 k 1 [E] [S] d[e ] / dt = - k 1 [E] [S] + k 2 [ES] + k 3 [ES] ES ---> E + S ES ---> E + P : k2 : k3 k 2 [ES] k 3 [ES] d[es ] / dt = + k 1 [E] [S] - k 2 [ES] - k 3 [ES] Similarly for other species... Bio/Chemical Kinetics Made Easy 10 5

System of Simple, Simultaneous Equations HOW DYNAFIT PROCESSES YOUR BIOCHEMICAL EQUATIONS k 1 E + S E.S E + P k 2 k 3 "The LEGO method" of deriving rate equations Input (plain text file): Rate terms: Rate equations: E + S ---> ES : k1 k 1 [E] [S] ES ---> E + S : k2 k 2 [ES] ES ---> E + P : k3 k 3 [ES] Bio/Chemical Kinetics Made Easy 11 DynaFit can analyze many types of experiments MASS ACTION LAW AND MASS CONSERVATION LAW IS APPLIED IN THE SAME WAY EXPERIMENT DYNAFIT DERIVES A SYSTEM OF... chemistry biophysics pharmacology enzymology Kinetics (time-course) Equilibrium binding Initial reaction rates Ordinary differential equations (ODE) Nonlinear algebraic equations Nonlinear algebraic equations Bio/Chemical Kinetics Made Easy 12 6

Biochemical / Biophysical Kinetics Made Easy Software DYNAFIT in drug discovery research Petr Kuzmič, Ph.D. BioKin, Ltd. 1. Theory: differential equation models - DYNAFIT software 2. Example: lanthascreen Eu assay in kinetic mode - p38a kinase / antibody / tracer - p38α kinase / antibody / tracer / desatinib Kinase Antibody Tracer Inhibitor assay A FOUR-COMPONENT MIXTURE 1 2 3 4 Bio/Chemical Kinetics Made Easy 14 7

Kinase Antibody Tracer Inhibitor: mechanism PURPOSE: OBTAIN RATE CONSTANTS FOR INHIBITOR ASSOCIATION & DISSOCIATION E A T I... enzyme... antibody (FRET donor)... tracer (FRET acceptor)... inhibitor four components five complexes (3 binary, 2 ternary) six unique rate constants Bio/Chemical Kinetics Made Easy 15 Rate constants and receptor-ligand residence time IS IT WORTH CHASING AFTER RATE CONSTANTS? Mbalaviele et al. (2009) J. Pharm. Exp. Ther. 329, 14-25 PHA-408 is an ATP competitive inhibitor, which binds IKK-2 tightly with a relatively slow off rate. Puttini et al. (2008) haematologica 93, 653-61 The present results suggest a slower off-rate (dissociation rate) of [a novel Abl kinase inhibitor] compared to imatinib as an explanation for the increased cellular activity of the former. Tummino & Copeland (2008) Biochemistry 47, 5481-92... the extent and duration of responses to receptor-ligand interactions depend greatly on the time period over which the ligand is in residence on its receptor. Bio/Chemical Kinetics Made Easy 16 8

Let s look at Kinase + Antibody + Tracer only. No Inhibitor yet. Bio/Chemical Kinetics Made Easy 17 Research plan: Stepwise model building ASSUME THAT THE ANTIBODY AND THE PROBE BIND INDEPENDENTLY 1. get k aa and k da 2. get k at and k dt only then add the unknown inhibitor Try to find conditions that might allow treating this as a simple A + B (two-component) system. Bio/Chemical Kinetics Made Easy 18 9

Classical method: k (obs) assuming [Antibody] >> [Kinase] GOODRICH & KUGEL (2006) Binding and Kinetics for Molecular Biologists, pages 91-95 and k -1 and k -1 Bio/Chemical Kinetics Made Easy 19 Enzyme + Antibody at very large excess of [Tracer] (pt. 1) THIS MIGHT ALLOW US TO TREAT THIS AS A SIMPLE A + B (TWO-COMPONENT) SYSTEM METHOD: 1. Incubate Tracer & Kinase - [Tracer] fixed, very large excess - [Kinase] varied 2. Wait 10 minutes to equilibrate 3. Add [Antibody] exponential fit k (obs) = 0.0019 s -1 4. Measure increase in fluorescence (T.E.A) [E] = 1.613 nm [A] = 0.2 nm [T] = 200 nm Bio/Chemical Kinetics Made Easy 20 10

Enzyme + Antibody at very large excess of [Tracer] (pt. 2) DYNAFIT INPUT SCRIPT : WE CAN USE SIMPLE ALGEBRAIC MODELS AS WELL [task] task = fit data = generic [parameters] t Ao, A, k [model] Ao = 0.1? A = 1? k = 0.001? F = Ao + A*(1 - exp(-k*t)) Bio/Chemical Kinetics Made Easy 21 Enzyme + Antibody at very large excess of [Tracer] (pt. 3) TRY TO FIT k (obs) TO THE STRAIGHT LINE MODEL EQUATION 0.003 0.0025 Determination of "off" / "on" rate constants: "k (app) method"?! not a straight line 0.002 k(app), 1/sec 0.0015 0.001 0.0005 0 0 0.5 1 1.5 2 2.5 3 3.5 [Kinase], nm Bio/Chemical Kinetics Made Easy 22 11

Enzyme + Antibody at very large excess of [Tracer] (pt. 4) POSSIBLE REASONS FOR THE NONLINEARITY OF k(app) VS. [Kinase] PLOT 1. [Kinase] is not at very large excess over [Antibody] at all times Goodrich & Kugel (2006), p. 95 2. Signal in LanthaScreen not strictly proportional to concentrations? The emission ratio is calculated as the 665 nm signal divided by the 615 nm signal. 3. Kinase concentrations being off their nominal values? Bio/Chemical Kinetics Made Easy 23 Enzyme + Antibody at very large excess of [Tracer] (pt. 5) GLOBAL FIT TO A MECHANISTIC MODEL [task] task = fit data = progress [mechanism] E + Ab <===> E.Ab : kaa kda [constants] kaa = 0.001? kda = 0.001? [concentrations] Ab = 0.2 [responses] E.Ab = 3? [data]... file d07 concentration E = 3.1250? file d06 concentration E = 1.5625? file d05 concentration E = 0.7813?... Bio/Chemical Kinetics Made Easy 24 12

Enzyme + Antibody at very large excess of [Tracer] (pt. 6) GLOBAL FIT TO A MECHANISTIC MODEL: BEST-FIT MODEL PARAMETERS k on = 0.92 10 6 M -1 s -1 k off = 0.00061 s -1 K d = k off / k on = 0.66 nm Signal in LanthaScreen not strictly proportional to concentrations? Bio/Chemical Kinetics Made Easy 25 Enzyme + Antibody at very large excess of [Tracer] (pt. 7) FIT AN EQUILIBRIUM BINDING MODEL TO END-OF-TRACE SIGNAL VALUES [task] task = fit data = equilibria [Kinase] [mechanism] E + Ab <===> E.Ab : KdA dissoc [constants] ; nm... KdA = 0.7? K da = 0.6 nm Bio/Chemical Kinetics Made Easy 26 13

Enzyme + Antibody at very large excess of [Tracer] (pt. 8) SUMMARY RESULTS Kinase Antibody dissociation equilibrium constant is around 0.7 nm The association rate constant is 0.9 10 6 M -1 s -1 ( diffusion control ) The half-time for dissociation is about 20 minutes ( slow ) CONCLUSIONS At nanomolar concentrations of [Kinase] and [Antibody] there is always a mixture of all three species (E, Ab, E.Ab) Diluting any kinase/antibody stock solution will cause the antibody to fall off the E.Ab complex This falling off of the antibody will be slow, measured in minutes Bio/Chemical Kinetics Made Easy 27 Research plan: Stepwise model building ASSUME THAT THE ANTIBODY AND THE PROBE BIND INDEPENDENTLY 1. get k aa and k da 2. get k at and k dt Try to find conditions that might allow treating this as a simple A + B (two-component) system. Bio/Chemical Kinetics Made Easy 28 14

Kinase - Antibody - Tracer: varied [Tracer] (pt. 1) RAW DATA Varied [Tracer], fixed [Kinase] + [Antibody] 0.35 0.3 signal 0.25 0.2 0.15 0.1 0.05 0.16 nm 0.41 nm 1.0 nm 2.6 nm 6.4 nm 16 nm 40 nm 0 0 100 200 300 400 500 600 700 time, sec 1. 5 μl 1.5 nm Kinase + 6 nm Antibody 2. 5 μl solvent 3. incubate 30 min 4. 5 μl Tracer, varied final concentration Bio/Chemical Kinetics Made Easy 29 Kinase - Antibody - Tracer: varied [Tracer] (pt. 1) RAW DATA: CLOSER LOOK AT HIGH [TRACER] CONCENTRATION ASSAY Varied [Tracer], fixed [Kinase] + [Antibody] 0.295 0.29 0.285 0.28 signal 0.275 0.27 0.265 0.26 0.255 0.25 0.245 0 100 200 300 400 500 600 700 time, sec 40 nm? 1. 5 μl 1.5 nm Kinase + 6 nm Antibody 2. 5 μl solvent 3. incubate 30 min 4. 5 μl Tracer, 40 nm final concentration Bio/Chemical Kinetics Made Easy 30 15

Gradual loss of signal upon dilution: Invitrogen literature RESULTS FROM POSTER PRESENTED BY INVITROGEN antibody falling off Bio/Chemical Kinetics Made Easy 31 Problem: Can t use classical method based on k (app) THIS IS DEFINITELY NOT A RISING EXPONENTIAL Varied [Tracer], fixed [Kinase] + [Antibody] 0.295 0.29 0.285 0.28 signal 0.275 0.27 0.265 0.26 0.255 0.25 0.245 0 100 200 300 400 500 600 700 time, sec 40 nm Bio/Chemical Kinetics Made Easy 32 16

Solution: Global fit of both sets of experiments (pt. 1) EXPERIMENT #1: VARIED [TRACER] EXPERIMENT #2: VARIED [KINASE] [A] = 2 nm [E] = 0.5 nm [T] = 0.4... 40 nm [A] = 0.2 nm [E] = 0.098... 3.13 nm [T] = 200 nm Bio/Chemical Kinetics Made Easy 33 Solution: Global fit of both sets of experiments (pt. 2) DYNAFIT INPUT ( SCRIPT ) FILE [task] task = fit data = progress [mechanism] E + Tr <===> E.Tr : kat kdt E + Ab <===> E.Ab : kaa kda E.Tr + Ab <===> E.Tr.Ab : kaa kda E.Ab + Tr <===> E.Tr.Ab : kat kdt [constants] ; nm kaa = 0.001? kda = 0.001? kat = 0.001? kdt = 0.01?......... Bio/Chemical Kinetics Made Easy 34 17

Solution: Global fit of both sets of experiments (pt. 3) DYNAFIT OUTPUT: BEST-FIT PARAMETERS k on T = 2.7 10 6 M -1 s -1 k off T = 0.021 s -1 k on A = 0.92 10 6 M -1 s -1 k off A = 0.00061 s -1 K dt = 7.9 nm K da = 0.66 nm CONCLUSIONS Tracer is tight binding but not that tight : It will be impossible to completely prevent inhibitor rebinding by competition. Tracer is relatively fast off but not that fast (t 1/2 = 0.5 min): In certain experiments there could transients due to tracer interactions. It s a fairly complicated system: Once inhibitor is added all six rate constants need to be considered. Bio/Chemical Kinetics Made Easy 35 Now for the complete four-component system: Kinase + Antibody + Tracer + Inhibitor Bio/Chemical Kinetics Made Easy 36 18

Kinase - Antibody - Tracer - Inhibitor: data KINASE: p38α ANTIBODY: anti-gst TRACER: Invitrogen Tracer-199 INHIBITOR: desatinib Data: Bryan Marks, Invitrogen EXPERIMENT: 1. incubate [E] = 4 nm [Ab] = 40 nm [In] = varied 30 minutes 2. dilute 1:20 with Tracer final concentrations signal 0.25 0.20 0.15 0.10 0 56 167 500 nm [In] [E] = 0.2 nm [Ab] = 2 nm [Tr] = 100 nm [In] = varied 0.05 0.00 0 100 200 300 t, sec Bio/Chemical Kinetics Made Easy 37 Kinase - Antibody - Tracer - Inhibitor: fitting model AUTOMATICALLY DERIVED BY DYNAFIT system of simultaneous ordinary differential equations [mechanism] DynaFit Input d[e]/dt = - k ai [E][In] + k di [E.In] - k at [E][Tr] + k dt [E.Tr] - k aa [E][Ab] + k da [E.Ab] d[in]/dt E + = In - k ai [E][In] <===> + k di [E.In] - k ai [E.Ab][In] + k di :[E.In.Ab] kai kdi d[e.in]/dt E + Tr = + k ai <===> [E][In] - k di E.Tr [E.In] - k aa [E.In][Ab] + : k da [E.In.Ab] kat kdt d[tr]/dt = - k at [E][Tr] + k dt [E.Tr] - k at [E.Ab][Tr] + k dt [E.Tr.Ab] E + Ab <===> E.Ab : kaa kda d[e.tr]/dt = + k at [E][Tr] - k dt [E.Tr] - k aa [E.Tr][Ab] + k da [E.Tr.Ab] d[ab]/dt E.In = -+ k aa [E][Ab] <===> + k da [E.Ab] E.In.Ab - k aa [E.In][Ab] : + k da [E.In.Ab] kaa - kkda aa [E.Tr][Ab] + k da [E.Tr.Ab] d[e.ab]/dt = k aa [E][Ab] - k da [E.Ab] - k ai [E.Ab][In] + k di [E.In.Ab] - k at [E.Ab][Tr] + k dt [E.Tr.Ab] d[e.in.ab]/dt E.Ab + = In + k aa [E.In][Ab] <===> -E.In.Ab k da [E.In.Ab] + k : ai [E.Ab][In] kai- k di [E.In.Ab] kdi d[e.tr.ab]/dt + = Ab + k aa <===> [E.Tr][Ab] - k da [E.Tr.Ab] + k at :[E.Ab][Tr] kaa- k dt [E.Tr.Ab] kda E.Ab + Tr <===> E.Tr.Ab : kat kdt Bio/Chemical Kinetics Made Easy 38 19

Kinase - Antibody - Tracer - Inhibitor: rate constants ASSUMPTION: INDEPENDENT BINDING SITES ONLY TWO ADDITIONAL RATE CONSTANTS 0.25 0.20 DATA 0.15 + MODEL signal 0.10 0.05 0.00 0 100 200 300 t, sec LEAST-SQUARES FIT k ai = k di = 2.1 10 9 M -1.s -1 19 s -1 PARAMETERS τ = 0.05 sec RESIDENCE TIME Bio/Chemical Kinetics Made Easy 39 Kinase - Antibody - Tracer - Inhibitor: state variables EVOLUTION OF SPECIES CONCENTRATIONS DURING THE KINETIC EXPERIMENT EXPERIMENT: 1. incubate [E] = 4 nm [Ab] = 40 nm [In] = 370 nm 30 minutes 0.15 In E Ab E Ab Tr E Ab 2. dilute 1:20 with Tracer final concentrations [E] = 0.2 nm [Ab] = 2 nm [Tr] = 100 nm [In] = 18.5 nm concentration, nm 0.10 0.05 Tr E optimize design! 0.00 0.0001 0.001 0.01 0.1 1 10 100 1000 10000 t, sec Bio/Chemical Kinetics Made Easy 40 20

Acknowledgments Bryan Marks: all kinase experiments Invitrogen, a.k.a. Life Technologies, Madison, Wisconsin Bio/Chemical Kinetics Made Easy 41 Questions? http://www.biokin.com Bio/Chemical Kinetics Made Easy 42 21